share_log

Wells Fargo Upgrades Celldex Therapeutics to Equal-Weight, Announces $27 Price Target

Wells Fargo Upgrades Celldex Therapeutics to Equal-Weight, Announces $27 Price Target

富国银行将Celldex Therapeutics上调至同等权重,宣布目标股价27美元
Benzinga ·  2023/11/10 06:27

Wells Fargo analyst Derek Archila upgrades Celldex Therapeutics (NASDAQ:CLDX) from Underweight to Equal-Weight and announces $27 price target.

富国银行分析师德里克·阿奇拉将Celldex Therapeutics(纳斯达克股票代码:CLDX)从减持上调至同等权重,并宣布了27美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发